Aktieanalys

FluoGuide Q1 2025: Phase II HNC readout around the corner - Redeye

{newsItem.title}

Redeye Publicerad: 28 May 10:56

Redeye comments on FluoGuide’s Q1 2025 report while the company’s phase II HNC interim readout draws ever closer (H2 2025e). We believe these data will pave the way for FG001 to enter pivotal HNC trials as soon as 2026e. Business development news should provide further catalysts in 2025e. We update our estimates and valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/1113191/fluoguide-q1-2025-phase-ii-hnc-readout-around-the-corner?utm_source=finwire&utm_medium=RSS

Nyheter om FluoGuide

Läses av andra just nu

Om aktien FluoGuide

Senaste nytt